🇺🇸 FDA
Patent

US 12059418

Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

granted A61KA61K31/42A61K31/422

Quick answer

US patent 12059418 (Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Aug 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/42, A61K31/422, A61K31/423, A61K31/427